# Study to Determine the Equivalence of Three Products Containing Metronidazole Benzoate.

> **NCT02146209** · PHASE1 · COMPLETED · sponsor: **Verisfield UK Ltd. Greek Branch** · enrollment: 6 (actual)

## Conditions studied

- Bacterial Infections

## Interventions

- **DRUG:** Metronidazole benzoate
- **DRUG:** Flagyl 125 mg/5 ml oral suspension
- **DRUG:** Flagyl 400 mg Tablets

## Key facts

- **NCT ID:** NCT02146209
- **Lead sponsor:** Verisfield UK Ltd. Greek Branch
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2014-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02146209

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02146209, "Study to Determine the Equivalence of Three Products Containing Metronidazole Benzoate.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02146209. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*